Phreesia (PHR)
(Delayed Data from NYSE)
$20.61 USD
+1.79 (9.51%)
Updated Jul 11, 2024 04:00 PM ET
After-Market: $20.61 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth A Momentum A VGM
Brokerage Reports
Phreesia, Inc. [PHR]
Reports for Purchase
Showing records 41 - 60 ( 170 total )
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Earnings Preview - Updated Thoughts on PHR VEEV Ahead of Earnings Next Week
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Healthcare IT: Proprietary Healthcare Credit Card Transaction Data
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Client Wins Show No Sign of Slowing; Reiterate Overweight Rating on Multi- Pronged Growth Story
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
F4Q Beat; FY Revenue Guide a Touch Light (Likely to Set Up for Beats), but Profitability Better than Consensus; Balaji Appointed as New CFO
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Healthcare IT: Proprietary Healthcare Credit Card Transaction Data
Provider: KeyBanc Capital Markets
Analyst: Research Department